Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China
· Delayed Price · Currency is CNY 24.97
+0.01 (0.04%)
At close: Mar 6, 2026
SHE:002287 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,416 | 2,336 | 2,040 | 2,040 | 1,766 | Upgrade
|
| Other Revenue | - | 2.19 | 5.55 | 4.63 | 4.06 | Upgrade
|
| Revenue | 2,416 | 2,338 | 2,045 | 2,045 | 1,770 | Upgrade
|
| Revenue Growth (YoY) | 3.34% | 14.32% | 0.02% | 15.49% | 19.22% | Upgrade
|
| Cost of Revenue | - | 419.55 | 324.7 | 325.52 | 269.7 | Upgrade
|
| Gross Profit | 2,416 | 1,918 | 1,720 | 1,719 | 1,501 | Upgrade
|
| Selling, General & Admin | - | 1,280 | 1,162 | 1,107 | 986.35 | Upgrade
|
| Research & Development | - | 66.73 | 58.63 | 55.09 | 70.82 | Upgrade
|
| Other Operating Expenses | 1,653 | 34.76 | 32.26 | 29.47 | 28.58 | Upgrade
|
| Operating Expenses | 1,653 | 1,382 | 1,253 | 1,192 | 1,084 | Upgrade
|
| Operating Income | 762.95 | 536.7 | 467.52 | 527.71 | 416.45 | Upgrade
|
| Interest Expense | - | -57.79 | -63.07 | -56.42 | -53.43 | Upgrade
|
| Interest & Investment Income | - | 4.19 | 41.92 | 16.96 | 340.33 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | -0.03 | -0.02 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -28.78 | -0.02 | -1.16 | -3.56 | -2.46 | Upgrade
|
| EBT Excluding Unusual Items | 734.17 | 483.08 | 445.19 | 484.68 | 700.88 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -15.77 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 100.32 | 37.07 | -37.08 | 20.69 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.32 | 0 | -0.07 | Upgrade
|
| Asset Writedown | - | -0.58 | -0.3 | -1.22 | -0.35 | Upgrade
|
| Other Unusual Items | - | 63.43 | 162.14 | 72.82 | 82.54 | Upgrade
|
| Pretax Income | 734.17 | 646.24 | 644.41 | 519.2 | 787.91 | Upgrade
|
| Income Tax Expense | 87.94 | 64.87 | 65.24 | 49.56 | 77.09 | Upgrade
|
| Earnings From Continuing Operations | 646.23 | 581.37 | 579.18 | 469.64 | 710.83 | Upgrade
|
| Minority Interest in Earnings | - | 0.91 | 2.02 | 2.9 | 5.05 | Upgrade
|
| Net Income | 646.23 | 582.28 | 581.2 | 472.54 | 715.88 | Upgrade
|
| Net Income to Common | 646.23 | 582.28 | 581.2 | 472.54 | 715.88 | Upgrade
|
| Net Income Growth | 10.98% | 0.19% | 22.99% | -33.99% | 77.21% | Upgrade
|
| Shares Outstanding (Basic) | 544 | 530 | 530 | 530 | 529 | Upgrade
|
| Shares Outstanding (Diluted) | 544 | 530 | 530 | 530 | 529 | Upgrade
|
| Shares Change (YoY) | 2.51% | 0.03% | -0.05% | 0.21% | 0.12% | Upgrade
|
| EPS (Basic) | 1.19 | 1.10 | 1.10 | 0.89 | 1.35 | Upgrade
|
| EPS (Diluted) | 1.19 | 1.10 | 1.10 | 0.89 | 1.35 | Upgrade
|
| EPS Growth | 8.27% | 0.15% | 23.05% | -34.13% | 77.01% | Upgrade
|
| Free Cash Flow | - | 201.31 | 458.59 | 13.29 | 909.35 | Upgrade
|
| Free Cash Flow Per Share | - | 0.38 | 0.86 | 0.03 | 1.72 | Upgrade
|
| Dividend Per Share | - | 0.380 | 0.480 | 0.390 | 0.590 | Upgrade
|
| Dividend Growth | - | -20.83% | 23.08% | -33.90% | 73.53% | Upgrade
|
| Gross Margin | 100.00% | 82.06% | 84.12% | 84.08% | 84.77% | Upgrade
|
| Operating Margin | 31.58% | 22.96% | 22.86% | 25.81% | 23.52% | Upgrade
|
| Profit Margin | 26.75% | 24.91% | 28.42% | 23.11% | 40.43% | Upgrade
|
| Free Cash Flow Margin | - | 8.61% | 22.42% | 0.65% | 51.36% | Upgrade
|
| EBITDA | 870.95 | 644.7 | 552.96 | 604.13 | 476.77 | Upgrade
|
| EBITDA Margin | 36.05% | 27.57% | 27.04% | 29.54% | 26.93% | Upgrade
|
| D&A For EBITDA | 108 | 108 | 85.43 | 76.42 | 60.32 | Upgrade
|
| EBIT | 762.95 | 536.7 | 467.52 | 527.71 | 416.45 | Upgrade
|
| EBIT Margin | 31.58% | 22.96% | 22.86% | 25.81% | 23.52% | Upgrade
|
| Effective Tax Rate | 11.98% | 10.04% | 10.12% | 9.54% | 9.78% | Upgrade
|
| Revenue as Reported | - | 2,338 | 2,045 | 2,045 | 1,770 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.